Comparison of the effects of nebivolol versus metoprolol succinate on endothelial function and large artery stiffness

Trial Profile

Comparison of the effects of nebivolol versus metoprolol succinate on endothelial function and large artery stiffness

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2012

At a glance

  • Drugs Nebivolol (Primary) ; Metoprolol succinate
  • Indications Essential hypertension
  • Focus Biomarker; Pharmacodynamics
  • Acronyms NEMENDAS
  • Sponsors Berlin Chemie; Menarini
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Sep 2012 Results published in the Scandinavian Journal of Clinical and Laboratory Investigation.
    • 02 May 2011 Results published in Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top